1. 1446PManagement of leptomeningeal metastases in EGFR mutated non-small cell lung cancer: Analysis of tyrosine kinase inhibitors sequence. (23rd October 2018) Authors: Flippot, R; Auclin, E; Biondani, P; Le Rhun, E; Adam, J; Planchard, D; Caramella, C; Le Pechoux, C; Lacroix, L; Gazzah, A; Mezquita, L; Besse, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS10.4 Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for leptomeningeal metastasis from breast cancer - a randomized study. Final results. (6th September 2019) Authors: Le Rhun, E; Wallet, J; Mailliez, A; Le Deley, M; Rodrigues, I; Boulanger, T; Lorgis, V; Barriere, J; Robin, Y; Weller, M; Bonneterre, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS2.4 Angiotensin II Receptor Blockers, steroids and radiotherapy in glioblastoma - A randomized multicenter trial (ASTER Trial). An ANOCEF Study. (19th September 2018) Authors: URSU, R; Thomas, L; Psimaras, D; Chinot, O; Le Rhun, E; Ricard, D; Charissoux, M; Cuzzubbo, S; Sejalon, F; Quillien, V; Hoang-Xuan, K; Ducray, F; Portal, J; Levy-Piedbois, C; Vicaut, E; Carpentier, A Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway. (6th September 2019) Authors: Frappaz, D; Barritault, M; Montané, L; Laigle-Donadey, F; Chinot, O; Le Rhun, E; Bonneville-Levard, A; Meyronnet, D; Garin, G; Pérol, D Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS8.6 Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02. (6th September 2019) Authors: Le Rhun, E; von Achenbach, C; Sahm, F; Wang, S S; Neidert, M C; Rushing, E; Lawhon, T; Schneider, H; von Deimling, A; Weller, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P01.032 Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. (19th September 2018) Authors: Le Rhun, E; Genbrugge, E; Stupp, R; Chinot, O L; Nabors, L B; Cloughesy, T; Reardon, D A; Wick, W; Gorlia, T; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P01.034 Prospective evaluation of alternative therapies in glioma patients in France. (19th September 2018) Authors: Le Rhun, E; Lebrun Frenay, C; Devos, P; Darlix, A; Lorgis, V; Ahle, G; Boone, M; Taillandier, L; Curtit, E; Gras, L; Bourg, V; Ramirez, C; Reyns, N; Weller, M; Simon, N Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma. (19th September 2018) Authors: Le Rhun, E; Devos, P; Houillier, C; Cartalat-Carel, S; Chinot, O; Di Stefano, A; Reyns, N; Dubois, F; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗